Europe Sexually-Transmitted Diseases Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This new 318-page report provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in major European countries.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as the proprietary data files was conducted.



Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. Chlamydia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Human Herpes Virus-6 (HHV-6)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Papillomavirus (HPV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Syphilis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed by:
Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers
C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers
Sales and Market Shares
V. Italy: Market Size, Growth and Major Suppliers
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers
Sales and Market Shares
VIII. UK: Market Size, Growth and Major Suppliers
Sales and Market Shares

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols

- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables


Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Pap Smear/HPV Tests
Major Companies Developing or Marketing Syphilis Tests
France
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Chlamydia Diagnostics Sales by Major Supplier
France
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
France
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
France
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Herpes Testing Market Diagnostics Sales
by Major Supplier

France
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Papillomavirus (HPV) Test Volume and Diagnostics Sales
Forecast by Market Segment
France
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
France
Syphilis Testing Market Diagnostics Sales
by Major Supplier
Germany
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Germany
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment

Germany
Herpes Testing Market Diagnostics Sales
by Major Supplier
Germany
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Germany
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Germany
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
Italy
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment

Italy
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
Italy
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Italy
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chancroid Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Chlamydia Diagnostics Sales by Major Supplier
Spain
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
Spain
Herpes Type VI Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Herpes Testing Market Diagnostics Sales
by Major Supplier

Spain
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
Spain
Syphilis Testing Market Diagnostics Sales
by Major Supplier
U.K.
Chancroid
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment

U.K.
Herpes Type VI Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Herpes Testing Market Diagnostics Sales
by Major Supplier
U.K.
PAP Smear Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Papillomavirus (HPV) Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Syphilis Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Syphilis Testing Market Diagnostics Sales
by Major Supplier

Europe Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests:France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive five-country report contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology

USD 17500 View Report

Global Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

LeadingMarketResearch.com new seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the

USD 24500 View Report

U.S. 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023

About This ReportThis new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,

USD 2450 View Report

U.K. 8 Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts, 2019-2023

About This ReportThis new 280-page report presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear,

USD 1950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available